Home / Drug shortages / Methylphenidate Hydrochloride Tablet, Extended Release

Methylphenidate Hydrochloride Tablet, Extended Release — FDA Drug Shortage

Current — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Methylphenidate Hydrochloride Tablet, Extended Release (tablet) from Teva Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 07/26/2023. Reported reason: Other

Shortage Details

Status
Current
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
62037-727-01
Dosage Form
Tablet
Presentation
Methylphenidate Hydrochloride, Tablet, Extended Release, 54 mg (NDC 62037-727-01)
Initial Posting
07/26/2023
Revised Date

Reason

Other

FDA data resources